Management of Complex Renal Cysts

Classification and Risk Assessment

The American Urological Association recommends that complex renal cysts be categorized using the Bosniak classification system, which predicts malignancy risk: Bosniak I and II (simple cysts) have ~0% risk, Bosniak IIF ~10% risk, Bosniak III ~50% risk, and Bosniak IV ~100% risk 3
High-quality, multiphase, cross-sectional abdominal imaging (CT or MRI) is essential for optimal characterization of complex renal cysts, with MRI demonstrating higher specificity than CT (68.1% vs 27.7%) in characterizing renal lesions 4

The American Urological Association recommends intervention for Bosniak III and IV cysts when the anticipated oncologic benefits outweigh the risks of treatment and competing risks of death, with nephron-sparing approaches prioritized whenever feasible 1
For cT1a tumors (<7 cm), partial nephrectomy is the preferred intervention to preserve renal function, especially in patients with solitary kidney, bilateral tumors, or preexisting chronic kidney disease 1

The American Urological Association recommends prioritizing preservation of renal function through nephron mass preservation and avoidance of prolonged warm ischemia, with negative surgical margins as a priority while minimizing removal of normal parenchyma 5
Consider enucleation in patients with familial RCC, multifocal disease, or severe CKD to optimize parenchymal mass preservation, and a minimally invasive approach should be considered when it would not compromise oncologic, functional, and perioperative outcomes 5

The American Urological Association recommends that RMB be considered when a mass is suspected to be hematologic, metastatic, inflammatory, or infectious, with core biopsies not recommended for purely cystic renal masses due to low diagnostic yield unless areas with a solid pattern are present 1
The sensitivity (97%), specificity (94%), and positive-predictive-value (99%) of core RMB are excellent, but the negative-predictive-value is only 81%, with a non-diagnostic rate of approximately 14% that can be reduced with repeat biopsy 1

Patients with a complex renal cyst should have CKD stage assigned based on glomerular filtration rate (GFR) and degree of proteinuria, with consideration of referral to nephrology for patients with high risk of CKD progression 1
Pathologic evaluation of the adjacent renal parenchyma should be performed after partial or radical nephrectomy to assess for possible nephrologic disease, and patients younger than 46 years with a renal mass should be considered for genetic evaluation for hereditary RCC syndromes 5